Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 165

1.

Selective and super-selective C-arm based cone beam CT angiography (CBCTA) with DynaCT for CyberKnife radiosurgery planning of intracranial arteriovenous malformations (AVMs).

Holmes OE, Szanto J, Abitbul VT, Al Mansoori T, Al-Qahtani H, Sinclair J, Iancu D, Malone S.

J Radiosurg SBRT. 2018;5(4):305-313.

2.

Reducing errors in prostate tracking with an improved fiducial implantation protocol for CyberKnife based stereotactic body radiotherapy (SBRT).

Holmes OE, Gratton J, Szanto J, Vandervoort E, Doody J, Henderson E, Morgan SC, O'Sullivan J, Malone S.

J Radiosurg SBRT. 2018;5(3):217-227.

3.

Pre-operative versus post-operative radiosurgery for brain metastasis: Effects on treatment volume and inter-observer variability.

Vellayappan BA, Doody J, Vandervoort E, Szanto J, Sinclair J, Caudrelier JM, Malone S.

J Radiosurg SBRT. 2018;5(2):89-97.

4.

Comparison of four techniques for spine stereotactic body radiotherapy: Dosimetric and efficiency analysis.

Aljabab S, Vellayappan B, Vandervoort E, Bahm J, Zohr R, Sinclair J, Caudrelier JM, Szanto J, Malone S.

J Appl Clin Med Phys. 2018 Mar;19(2):160-167. doi: 10.1002/acm2.12271. Epub 2018 Feb 7.

5.

The possible role of CD8+/Vα7.2+/CD161++ T (MAIT) and CD8+/Vα7.2+/CD161lo T (MAIT-like) cells in the pathogenesis of early-onset pre-eclampsia.

Meggyes M, Szanto J, Lajko A, Farkas B, Varnagy A, Tamas P, Hantosi E, Miko E, Szereday L.

Am J Reprod Immunol. 2018 Feb;79(2). doi: 10.1111/aji.12805. Epub 2017 Dec 19.

PMID:
29265516
6.

Utility of CT-cisternogram for radiosurgery in trigeminal neuralgia: A not-to-be forgotten technique.

Vellayappan B, Chakraborty S, Althagafi S, MacLean J, Szanto J, Sinclair J, Malone S.

J Med Imaging Radiat Oncol. 2016 Apr;60(2):283-7. doi: 10.1111/1754-9485.12423. Epub 2015 Dec 2.

PMID:
26633581
7.

Influencing effect of heat-treatment on radon emanation and exhalation characteristic of red mud.

Sas Z, Szántó J, Kovács J, Somlai J, Kovács T.

J Environ Radioact. 2015 Oct;148:27-32. doi: 10.1016/j.jenvrad.2015.06.002. Epub 2015 Jun 19.

PMID:
26093854
8.

Dynamic CT angiography for cyberknife radiosurgery planning of intracranial arteriovenous malformations: a technical/feasibility report.

Haridass A, Maclean J, Chakraborty S, Sinclair J, Szanto J, Iancu D, Malone S.

Radiol Oncol. 2015 Mar 25;49(2):192-9. doi: 10.1515/raon-2015-0006. eCollection 2015 Jun. Erratum in: Radiol Oncol. 2015 Sep;49(3):314.

9.
10.

Post-operative management of primary glioblastoma multiforme in patients over 60 years of age.

Daróczi B, Szántó E, Tóth J, Barzó P, Bognár L, Bakó G, Szántó J, Mózes P, Hideghéty K.

Ideggyogy Sz. 2013 Nov 30;66(11-12):391-8.

PMID:
24555238
11.

Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study.

Hunyadi J, András C, Szabó I, Szántó J, Szluha K, Sipka S, Kovács P, Kiss A, Szegedi G, Altorjay I, Sápy P, Antal-Szalmás P, Tóth L, Fazekas G, Rajnavölgyi É.

Pathol Oncol Res. 2014 Apr;20(2):357-65. doi: 10.1007/s12253-013-9704-3. Epub 2013 Oct 28.

PMID:
24163303
12.

CyberKnife for inoperable renal tumors: Canadian pioneering experience.

Nair VJ, Szanto J, Vandervoort E, Cagiannos I, Breau R, Malone C, Avruch L, Pantarotto J, Malone S.

Can J Urol. 2013 Oct;20(5):6944-9. Review.

PMID:
24128835
13.

Sci-Thur AM: Planning - 10: Improved dosimetric accuracy for patient specific quality assurance using a dual-detector measurement method for cyberknife output factors.

Vandervoort E, La Russa D, Ploquin N, Kadir IAE, Szanto J.

Med Phys. 2012 Jul;39(7Part2):4621. doi: 10.1118/1.4740095.

PMID:
28516540
14.

Correlations between clinicopathological parameters and molecular signatures of primary tumors for patients with stage T3n0 colorectal adenocarcinomas: a single center retrospective study on 100 cases.

András C, Tóth L, Molnár C, Tanyi M, Csiki Z, Dezso B, Pósán J, Shemirani AH, Csiki E, Szántó J.

Hepatogastroenterology. 2012 Jun;59(116):1091-7. doi: 10.5754/hge12041.

PMID:
22414548
15.

Malignancies associated with systemic sclerosis.

Szekanecz É, Szamosi S, Horváth Á, Németh Á, Juhász B, Szántó J, Szücs G, Szekanecz Z.

Autoimmun Rev. 2012 Oct;11(12):852-5. doi: 10.1016/j.autrev.2012.02.021. Epub 2012 Mar 5. Review.

PMID:
22410174
16.

Investigation of β-catenin and E-cadherin expression in Dukes B2 stage colorectal cancer with tissue microarray method. Is it a marker of metastatic potential in rectal cancer?

Tóth L, András C, Molnár C, Tanyi M, Csiki Z, Molnár P, Szántó J.

Pathol Oncol Res. 2012 Apr;18(2):429-37. doi: 10.1007/s12253-011-9463-y.

PMID:
21975680
17.

[The emotions of oncologists].

Lazányi K, Molnár P, Bugán A, Kiss C, Szántó J, Gonda A, Tóth Z, Hernádi Z, Hadijev J, Remenyik E, Damjanovich L, Dinya T, Flaskó T, Bágyi P, Szluha K.

Magy Onkol. 2011 Sep;55(3):205-6, 208-12. doi: MagyOnkol.2011.55.3.205. Epub 2011 Feb 17. Hungarian.

18.

Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study.

Francz M, Egervari K, Kardos L, Toth J, Nemes Z, Szanto J, Szollosi Z.

J Clin Pathol. 2010 Apr;63(4):341-6. doi: 10.1136/jcp.2009.066852. Epub 2009 Dec 3.

PMID:
19965795
19.

[Anti-VEGF therapy with bevacizumab in breast cancer].

Tóth J, Gonda A, Szántó J.

Lege Artis Med. 2008 Oct;18(10):669-73. Hungarian.

PMID:
19227609
20.

[Prophylaxis of chemotherapy-induced vomiting and nausea].

Tóth J, Szántó J.

Magy Onkol. 2008 Dec;52(4):391-4. doi: 10.1556/MOnkol.52.2008.4.9. Review. Hungarian.

PMID:
19068468

Supplemental Content

Loading ...
Support Center